Medicine exchange will develop between Iran and Spain by the efforts of the biotechnology development headquarter. This is aimed at creating the infrastructure needed to achieve the export benefits of Iranian pharmaceutical companies.

One of the growing industries in Iran is the pharmaceutical industry. An industry that is driven by the efforts of Iranian youth and professionals to coordinate across sectors such as the Ministry of Health and Medical Education, the Vice-Presidency, the private sector, and other institutions involved in the knowledge production to drug market. Efforts have been made to provide high quality medicines manufactured in the country, which is a reason why international companies are demanding to buy these vital products. In this regard, a delegation of Arapharmed Co., one of the popular pharmaceutical companies of Spain, visited the abilities of Iranian manufacturing companies.

During this three-day visit, the representatives of Arapharmed Co. visited the research and production facilities of various companies, such as “Dorsa Pharmaceutical Co.”, “Tofigh Darou”, “Baran”, “Alborz”, “CinnaGen”, “Maad Accelerator”, “Shafa Darou”, “Zist Takhmir”, and “Endocrine Research Institute of Baqiyatallah University”. In addition to exchange of experiences, the prerequisites for cooperation between Iranian and Spanish parties were provided.

In the end, a contract was concluded between Iran and Spain to transfer technology and products.

Arapharmed Co. is one of the largest exporters of medicine to Iran and other regional countries and one of the most successful European companies that manufacture drugs. In these contracts, technology, raw materials and technical knowledge were exchanged between companies in various fields and the opportunity was provided to obtain appropriate export benefits for Iranian pharmaceutical companies.

A report by the public relations and information center of the Vice-Presidency for science and technology affairs